Reports and intelligence adds a report titled, “Global HPV Testing Market 2014-2018.” The global HPV testing market is expected to register a CAGR of 19.43% during the forecast period (2014-2018). The report provides deep insights on the global HPV testing market.
Browse full report at: http://www.reportsandintelligence.com/global-hpv-testing-2014-2018-market
Human papillomavirus is popularly known as HPV. It is a form of DNA virus, which spreads productive infections only in mucous membranes or keratinocytes of the skin. There are more than 30 to 40 types of HPVs, which are transmitted through sexual contact between humans. HPV is different from HSV and HIV. HPV is a common virus that affects almost every sexually active man or woman during their lifetime. Some of the HPVs can also cause cancer and genital warts.
The growing number of HPV patients has led to the growth of the HPV testing market. However, limited or less number of health clinics across various regions is a major hurdle in the growth of the HPV testing market. The report also provides information and analysis of the latest market trends, technological advancements, mergers and acquisitions by the companies, product type and applications, etc. Geographically, the report is segmented into EMEA, America and the APAC regions.
The report provides detail analysis of the questions related to market size in 2018, latest market trends, drivers & restraints, factors influencing the growth of the market, technological advancements and key vendors in the market. Prominent palyers profiled in the report are Arbor Vita Corp., Abbott Molecular Inc., Becton, Dickinson and Co., Quest Diagnostics Inc., IncellDx Inc., Ventana Medical Systems Inc and Trovagene Inc.
Table of Contents:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Geographical Segmentation
08. Buying Criteria
Please join StudyMode to read the full document